DC Circ. Revives Terror-Funding Case Against AstraZeneca
The D.C. Circuit on Tuesday revived a lawsuit accusing AstraZeneca, Pfizer and several other pharmaceutical companies of helping to finance terror acts — through lucrative medical goods contracts with Iraq's health...To view the full article, register now.
Already a subscriber? Click here to view full article